iRhythm Technologies (IRTC) Projected to Post Quarterly Earnings on Thursday

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) is anticipated to release its Q1 2025 earnings data after the market closes on Thursday, May 1st. Analysts expect iRhythm Technologies to post earnings of ($0.89) per share and revenue of $153.39 million for the quarter.

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.29) by $0.30. iRhythm Technologies had a negative net margin of 19.14% and a negative return on equity of 118.83%. The company had revenue of $164.33 million for the quarter, compared to analyst estimates of $158.30 million. On average, analysts expect iRhythm Technologies to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

iRhythm Technologies Stock Performance

Shares of NASDAQ:IRTC traded down $1.39 during trading hours on Tuesday, hitting $105.26. The stock had a trading volume of 26,930 shares, compared to its average volume of 456,693. The stock's fifty day simple moving average is $104.35 and its 200 day simple moving average is $95.44. iRhythm Technologies has a 1-year low of $55.92 and a 1-year high of $128.52. The firm has a market capitalization of $3.36 billion, a price-to-earnings ratio of -28.92 and a beta of 1.45. The company has a debt-to-equity ratio of 9.00, a quick ratio of 6.12 and a current ratio of 6.27.

Analysts Set New Price Targets

A number of research firms recently commented on IRTC. Needham & Company LLC raised their price objective on shares of iRhythm Technologies from $125.00 to $138.00 and gave the company a "buy" rating in a research note on Friday, February 21st. The Goldman Sachs Group raised their price objective on shares of iRhythm Technologies from $91.00 to $124.00 and gave the company a "neutral" rating in a research note on Monday, February 24th. Wells Fargo & Company raised their price objective on shares of iRhythm Technologies from $86.00 to $104.00 and gave the company an "equal weight" rating in a research note on Friday, February 21st. Oppenheimer raised their price objective on shares of iRhythm Technologies from $105.00 to $120.00 and gave the company an "outperform" rating in a research note on Wednesday, January 8th. Finally, StockNews.com upgraded shares of iRhythm Technologies from a "sell" rating to a "hold" rating in a report on Monday, February 24th. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, iRhythm Technologies presently has an average rating of "Moderate Buy" and a consensus price target of $119.73.

About iRhythm Technologies

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.